Researchers at Fox Chase Cancer Center have isolated an engineered antibody, GS45, that targets the Müllerian Inhibiting Substance Type II Receptor on ovarian cancer cells. This unique target is scarce in normal tissue, reducing the risk of side effects associated with traditional targeted therapies.
A new 3-D cell culture technique using magnetic forces has been developed, allowing for the growth of cells in 3-D. This method promises to provide more accurate preclinical drug tests and better cancer research outcomes by mimicking the body's natural tissue structures.
Researchers have developed a new method for growing 3-D cell cultures using magnetic levitation, which more closely resembles the body's natural tissue structure. The technique has shown promising results in preclinical drug tests and may revolutionize cancer research.
Researchers have identified a peptide called iRGD that specifically targets and penetrates cancerous tumors, delivering diagnostic particles and medicines. This breakthrough could improve cancer treatment and reduce side effects.
Researchers at Texas A&M University discovered that phages, a type of virus, can destroy bacterial cell walls by producing an enzyme called endolysin. This finding may aid in the development of phage therapy to treat bacterial infections.
Bacteria have a novel RNA repair system that adds a methyl group to damaged RNA, making it impossible to cleave the site again. This discovery has implications for protecting cells against ribotoxins and understanding RNA interference in eukaryotes.
The article presents optimized ChIP protocol for mammalian cells, while recombineering methods are used to construct targeting vectors for conditional knockout mice. These techniques provide efficient and precise genetic modifications.
Researchers discover potential drugs that block the first step in the infection process, preventing flu viruses from infecting cells. This breakthrough could lead to a new genre of antivirals and be used to develop treatments for other medical problems.
Researchers at Texas A&M University have found that certain types of bacteria integrate invading DNA into their genetic makeup to increase their chances of survival. This process allows the bacteria to produce diverse progeny, which is essential for dispersal and adaptation to new environments.
Researchers have created a new onsite method to quickly diagnose tuberculosis, reducing diagnosis time from weeks to days. The test uses bacteriophages with green fluorescence protein to detect the deadly drug-resistant strains that can mingle undetected with treatable TB strains.
A team of researchers has discovered how the N4 phage injects its own RNA polymerase into E. coli bacterial cells, enabling it to create new proteins without host help. The unique property allows for potential therapeutic applications in killing E. coli bacteria.
Researchers at Arizona State University have developed a method to produce complex DNA nanostructures inside living cells, using the cell's copy machine to replicate millions of copies. This breakthrough could enable the scaling up of DNA nanotechnology and open up new possibilities for synthetic biology applications.
Researchers at NIST have identified a small biomolecule that binds specifically to hydroxyapatite, the key crystal structure of teeth and bones. This new peptide can be used as a nondestructive tag to monitor bone and tooth mineralization.
Biotech companies are developing novel biomarkers to improve cancer diagnostic tests, potentially reducing treatment costs. Researchers at various institutions, including the Ludwig Institute for Cancer Research and Wayne State University School of Medicine, are working on early detection tools for malignancies.
A new study by Yoshida et al. reveals that evolutionary dynamics can mask strong interactions between predators and prey, leading to cryptic dynamics in ecology. The research uses laboratory microcosms to demonstrate how rapid evolution of prey genotypes can influence predator-prey cycles.
Scientists discover new viruses that target specific types of bacteria, offering an alternative to conventional antibiotic therapy. The approach has potential to combat antibiotic resistance and superbug infections such as MRSA.
MIT and BU researchers develop modular system to design phages targeting specific bacterial biofilms, achieving high success rates. The technology has potential applications in treating infections and cleaning products.
A new nasal spray treatment using a virus enzyme shows promise in preventing acute otitis media and secondary pneumonia in mice infected with Streptococcus pneumoniae. The treatment uses lysine to eliminate bacteria from the ear, reducing the risk of middle ear infection.
A team of researchers investigated the mechanism of phage DNA packaging, directly testing the connector rotation hypothesis. They found that it is unlikely to be the correct mechanism, and instead suggest a nonrotating model where ATPases compress and extend alternately, drawing in the DNA.
Researchers discovered a genetic variation that enables adults to express higher levels of fetal hemoglobin, reducing their risk of Alzheimer's disease. The study also found that beta amyloid peptide has an affinity for adult hemoglobin, which may enhance its ability to wreak havoc in the brain.
Researchers analyzed ocean water samples from four regions, identifying over 91% new DNA sequences not present in existing databases. The study found that regional differences in geography and environment select for distinct viral communities.
Researchers compared two microbial killing mechanisms: chemical toxins and viral parasites. Chemical toxins are superior for resident defense against invaders, while viral parasites facilitate faster invasion when carriers are rare.
Researchers at Albert Einstein College of Medicine have developed a novel technique to insert genes into the P. falciparum genome, providing valuable information about its virulence and resistance to antimalarial drugs. This breakthrough should significantly speed up research efforts to bring malaria under control.
A $2.8M NIH grant enables researchers to explore a harmless bacteriophage, nicknamed the 'Bronx Bomber,' that disrupts the biofilm coating of Mycobacterium smegmatis, potentially leading to more effective TB treatments.
Researchers De Paepe and Taddei found that bacteriophages exhibit life history trade-offs between survival and reproduction, with rapid reproducers suffering higher casualties outside the host. Two physical parameters account for most of the observed variation in survival, suggesting a fundamental property of evolving entities.
Researchers catalogued and characterized 30 mycobacteriophages, finding 3,357 genes in 1,536 'phamilies' with significant genetic diversity. This discovery has implications for understanding diseases like tuberculosis and leprosy.
Researchers developed a phage-genomics educational platform, attracting high school and undergraduate students to scientific discovery. The study found that simplicity, flexibility, and ownership are key attributes of an effective science program.
Researchers have developed a new hybrid virus that can target tumors systemically to deliver an imaging or therapeutic gene, allowing for the monitoring of drug effectiveness at the molecular level. This breakthrough could lead to improved diagnosis, monitoring, and treatment of human cancers.
A new method for identifying bacteria uses genetically engineered phages that infect target bacteria, releasing biotin-capped phage progeny attached to quantum dots. The resulting phage-quantum dot complexes can be detected and counted using microscopy or spectroscopy, allowing for rapid identification of bacteria.
Liposome technology has been shown to improve tissue delivery of therapeutic compounds, achieving effects equivalent to 10-fold higher doses. Specific targeting of liposomes to inflamed cells in the synovium has also been successfully demonstrated, reducing synovial inflammation without conventional side effects.
Researchers identified a number of cas genes associated with CRISPR clusters, potentially involved in RNA-processing mechanisms. They propose that all CRISPR inserts are derived from viruses or plasmids, transcribed and silenced via Cas proteins.
The Burnham Institute will collaborate with a team of researchers to develop nano-devices that target tumor cells, improve diagnostics and tracking of cancer cells. The project aims to deliver imaging agents and therapeutics directly to cancer cells using 'nano-homing' devices.
A team of UCSD biochemists has discovered a mechanism for generating 10 trillion varieties of a single protein, providing a new tool for developing novel drugs. This finding, published in Nature Structural and Molecular Biology, uses the genetic mechanism used by a virus that infects bacteria to create a kaleidoscope of variants.
The US Army's Gamma Phage Assay has been approved by the FDA for human use within the Laboratory Response Network (LRN), enabling early detection of anthrax bioterrorism threats. This test, developed with CDC support, is a classical bacteriological method that uses a virus to identify B. anthracis.
Researchers employed a bacteriophage to learn how an HIV protein responds to new anti-viral molecules, identifying compounds with potential to overcome drug resistance. This approach enables faster and more effective drug discovery for other anti-viral therapies.
Three marine phages, sequenced from cyanobacteria in low-nutrient oceans, exhibit genes adapted for infecting photosynthetic bacteria. These genes may help the host maintain photosynthesis during infection, and could influence phage ecology and range.
Researchers found that marine viruses, known as cyanophages, require light to attach to and infect cyanobacteria, which are crucial for ocean health. This discovery could lead to more effective methods of controlling harmful algal blooms in the environment.
Scientists have made a significant breakthrough in understanding pemphigus, a deadly skin blistering disease. Researchers engineered antibodies that reproduce the disease in vitro and in mice, offering a new opportunity for targeted therapy development.
Phage nucleic acid transport poses a fascinating biophysical problem. Researchers used fluorescently labeled phage DNA to investigate the dynamics of DNA ejection from single phages, demonstrating that release is not an all-or-none process but rather a complex and stepwise process.
Hatfull, a Pitt professor, discusses ways to make research experiences available to students at all stages of education. He has turned high school students into
Researchers successfully targeted the key HIV protein Nef using small molecules, disrupting its interaction with other proteins. This breakthrough may lead to new drug therapies with improved treatment options.
Researchers at UCLA have discovered a new mechanism in bacteriophages that allows them to rapidly evolve new variants to target bacterial resistance. This discovery has the potential to create
Researchers found that bacteriophages can rapidly evolve new variants to target resistant bacteria, opening up possibilities for developing dynamic anti-microbial agents. The discovery could provide a renewable resource of smart antibiotics for treating bacterial diseases.
A study of 13,271 Salmonella infection cases in Sweden found that 87% were contracted abroad, with most coming from Spain, Greece, and Turkey. The number of diagnoses for a rare type of Salmonella Enteritidis increased dramatically among visitors to Greece in 2001.
Researchers have identified viral proteins that can kill specific bacteria, such as Streptococcus pneumoniae and Staphylococcus aureus, which cause various infections. These enzymes can be delivered orally or nasally to decolonize individuals in high-risk settings.
Researchers identified 31 novel polypeptide families that inhibit Staphylococcus aureus growth when expressed in bacteria. They used phage genomics to screen for small molecule inhibitors and found several compounds that inhibited bacterial growth and DNA synthesis.
Scientists have successfully synthesized a bacteriophage genome, paving the way for larger microbes to consume CO2 and pollutants. The Institute for Biological Energy Alternatives aims to harness microbiomes to produce fuels and reduce atmospheric carbon emissions.
Researchers at PhageTech identified phage-derived antimicrobial proteins that inhibit bacterial growth and kill bacteria in diverse ways. The company's technology platform has led to the discovery of novel bacterial targets essential to bacterial growth, which are being screened for small molecule compounds as potential new antibiotics.
Researchers at UCSD have identified two peptide sequences that bind to abnormal beta-amyloid plaques in Alzheimer's disease. The peptides may be used for diagnostic tests or coupled with molecules to inhibit plaque toxicity, making them a promising new approach to the disease.
A recent study published in PLOS Biology tracked the genomic activity of Plasmodium falciparum in human red blood cells, revealing a surprisingly simple pattern of gene expression. This finding could lead to the identification of the biological function of unknown genes and provide new insights into the life cycle of malaria parasites.
A joint U.S.-Georgian team aims to develop a novel treatment against bacterial pathogens causing salmonella infection. The grant supports phage therapy research to prevent massive outbreaks and address growing antibiotic resistance.
Bacteriophage, or phage, previously thought not to be infectious to humans, may be a new target for fighting certain bacteria that produce toxins. Scientists found that phage can transfer toxins and genes between bacteria, transforming harmless microbes into virulent bugs.
Researchers have discovered a new bacteriophage, CEV1, that can efficiently infect and kill E. coli O157:H7 in livestock gut systems. This natural approach could lead to an effective management strategy to eradicate the pathogen from livestock.
The study reveals a vast array of genomic diversity among the ten newly isolated phages, with varying genome lengths and unexpected similarities to bacterial genomes. This discovery challenges traditional classification systems and raises questions about the role of bacteriophages in evolution.
The study found that nearly a third of the E. faecalis genome consists of mobile or 'foreign' DNA, which plays a crucial role in helping the bacterium develop drug resistance. The analysis identified two sites in the genome related to vancomycin resistance, including a novel transposon carrying vanB resistance genes.
The new center at Dana-Farber will conduct therapeutic antibody research, providing high affinity human single-chain antibodies to support cancer research globally. Marasco's laboratory has constructed a large phage display library to quickly isolate antibodies against various cancer targets.
Researchers at the University of Florida have developed a novel approach to curing mice of Vibrio vulnificus, a deadly bacteria that causes flu-like symptoms and can be fatal. The treatment involves using a virus to attack the bacterial source, showing promise as an alternative to antibiotics for treating this disease.
The genome sequence of Shewanella oneidensis reveals its ability to remove toxic metals like chromium and uranium from the environment. Scientists have discovered a new bacterial phage that may enable genetic manipulation of Shewanella for specific bioremediation projects.
The complete genome sequence of B. suis reveals fundamental similarities with Brucella melitensis, a related species that causes similar disease in goats and humans. The study sheds light on the molecular mechanisms enabling closely-related species to target different host animals.
Researchers have developed a new agent using phage enzymes that can specifically target and eliminate millions of anthrax bacteria within seconds. This targeted killer also shows promise as an anthrax detection and decontamination tool, with potential applications in mailrooms or subway stations.